Does CPAP really extend life? The clearest evidence from a large real-world study
The strongest evidence that CPAP can extend lifespan comes from a 2024 study of over 14,000 real-world sleep apnea patients in Catalonia, Spain [1]. Researchers compared people who continued CPAP therapy with those who stopped it in 2011 and had no further prescriptions for years. Over a median follow-up of nearly 4 years (47.9 months), those who kept using CPAP had a 39% lower risk of dying from cardiovascular causes (hazard ratio 0.61). That means for every 100 cardiovascular deaths in the group that quit CPAP, only about 61 occurred in the group that stayed on therapy. The study also found a 13% lower risk of cardiovascular hospitalizations and a 16% lower risk of major adverse cardiovascular events (like heart attacks or strokes) among CPAP users. This is important because earlier randomized trials had failed to show this benefit, but those trials excluded many typical patients; this real-world study included a broader, older, sicker population that better represents who actually uses CPAP.
How CPAP protects the heart and brain: reversing damage and preventing strokes
CPAP extends life by directly reversing physical damage to the heart and reducing the risk of stroke. A 2022 study of 24 patients with atrial fibrillation (a common heart rhythm disorder) and moderate-to-severe sleep apnea showed that after at least 6 months of CPAP, the heart's electrical tissue actually healed [2]. Compared to the untreated group, CPAP users had faster electrical conduction (0.86 vs 0.69 meters per second) and higher voltage signals (2.30 vs 1.94 millivolts), meaning the heart muscle was healthier and less scarred. The proportion of abnormal, complex electrical points in the heart dropped from about 12% to under 9%. This reversal of 'atrial remodeling' is a key mechanism by which CPAP prevents deadly arrhythmias and heart failure.
Separately, sleep apnea is a major risk factor for stroke—60-80% of acute stroke patients have it [3]. CPAP treatment is being actively studied in the RISE-UP trial to see if it improves recovery after a stroke, because untreated apnea causes intermittent drops in oxygen that damage brain tissue. While that trial is still ongoing, the logic is clear: by stabilizing oxygen levels during sleep, CPAP prevents the chain reaction of hypoxia, inflammation, and blood pressure spikes that lead to both first-time and recurrent strokes.
What CPAP does NOT do (and why that doesn't matter for lifespan)
Interestingly, CPAP does not seem to extend life by correcting a simple blood problem. A 2023 study of 527 sleep apnea patients found that despite repeated nighttime oxygen drops, almost none had abnormally high red blood cell counts (erythrocytosis) [5]. The body actually destroys new red blood cells as soon as oxygen returns (a process called neocytolysis), and inflammation blocks iron availability. CPAP reduced some of the inflammatory markers but did not change hemoglobin levels. This means the lifespan benefit of CPAP comes from protecting the heart and brain, not from fixing anemia or blood thickness.
Similarly, a 2020 trial of 206 patients with coronary artery disease and non-sleepy sleep apnea found that CPAP did not significantly improve self-reported quality of life on standard questionnaires after 1 year, compared to no treatment [4]. However, within the CPAP group, several mental health and vitality scores did improve, especially in those whose daytime sleepiness and depression got better. The takeaway: CPAP's life-extending effects are real even in patients who don't feel dramatically better day-to-day, which is why objective measures like heart health matter more than subjective mood for predicting lifespan.
About These Sources
This answer is built on 5 peer-reviewed studies — published from 2020 to 2024, 2 from 2024 or later, 3 in Q1 journals, collectively cited 86 times — selected as the most relevant from 5 studies that passed quality screening, drawn from 48 papers retrieved from a database of over 500 million.
Sources used in this answer
Effect of CPAP Treatment on Cardiovascular Outcomes
In a real-world study of 14,552 sleep apnea patients, those who continued CPAP had a 39% lower risk of cardiovascular death and 13% fewer cardiovascular hospitalizations over nearly 4 years compared to those who stopped treatment.
Impact of CPAP on the Atrial Fibrillation Substrate in Obstructive Sleep Apnea
In a randomized trial of 24 atrial fibrillation patients with sleep apnea, 6+ months of CPAP reversed heart tissue damage, improving electrical conduction velocity (0.86 vs 0.69 m/s) and reducing abnormal electrical points (8.9% vs 11.9%).
0488 Exploring Study Recruitment Trends in the Acute Post-Stroke Setting
The RISE-UP trial reports that 60-80% of acute ischemic stroke patients have sleep apnea, and the study is investigating whether CPAP improves post-stroke recovery, highlighting the strong link between untreated apnea and stroke.
CPAP and Health-Related Quality of Life in Adults With Coronary Artery Disease and Nonsleepy Obstructive Sleep Apnea in the RICCADSA Trial.
In a randomized trial of 206 adults with coronary artery disease and non-sleepy sleep apnea, CPAP did not significantly improve quality-of-life scores compared to no CPAP after 1 year, though within the CPAP group mental health and vitality improved.
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis
In a study of 527 sleep apnea patients, over 98% did not have elevated hemoglobin; CPAP reduced inflammatory markers but did not change hemoglobin levels, showing that lifespan benefits come from heart/brain protection, not blood changes.